SCHEMBL5840230

SCHEMBL5840230

CCn1cnc2c(Nc3ccc(N)cc3)nc(NCCO)nc21

nearest known ligand 0.82

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 16/20 0.82
PRKCA P17252 5/20 0.58
CCNK O75909 2/20 0.54
CDK12 Q9NYV4 2/20 0.54
SRC P12931 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5839924 0.90 CDK1 (1.00) CDK1PRKCA
SCHEMBL5842067 0.90 CDK1 (0.84) CDK1PRKCASRC
SCHEMBL12982866 0.88 CDK1 (0.81) CDK1PRKCA
SCHEMBL5839245 0.88 CDK1 (0.81) CDK1PRKCACCNKCDK12
SCHEMBL5839064 0.85 CDK1 (0.75) CDK1PRKCACCNKCDK12
SCHEMBL5839632 0.84 CDK1 (0.71) CDK1PRKCACCNKCDK12
SCHEMBL5839355 0.82 CDK1 (1.00) CDK1PRKCA
SCHEMBL5840226 0.82 CDK1 (1.00) CDK1PRKCA
SCHEMBL5840504 0.82 CDK2 (0.62) CDK1SRC
SCHEMBL5840515 0.82 CDK2 (0.62) CDK1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091346-B1 Purine derivatives and processes for their preparation NOVARTIS AG (CH) 2006-08-15 US disclosed
EP-0874846-B1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2003-04-02 EP disclosed
CN-1066147-C Purine derivatives and process for preparing same 诺瓦提斯公司 2001-05-23 CN disclosed
CN-1202896-A Purine derivatives and processes for their preparation 诺瓦提斯公司 1998-12-23 CN disclosed
EP-0874846-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1998-11-04 EP disclosed
WO-1997016452-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-05-09 WO disclosed